alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
[Federal Register Volume 74, Number 167 (Monday, August 31, 2009)]
[Notices]
[Page 44895]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: E9-20935]


-----------------------------------------------------------------------

DEPARTMENT OF STATE

[Public Notice 6744]


Town Hall Meeting To Review the Implementation of the Terezin 
Declaration Provisions Relating to the Restitution of Nazi-Confiscated 
Art

    The Department of State's Special Envoy for Holocaust Issues is 
seeking the views of interested individuals and organizations regarding 
the implementation of the art restitution provisions of the June 30, 
2009 Terezin Declaration. The Declaration was the concluding document 
of the Conference on Holocaust Era Assets which met in Prague June 26-
30, 2009. The Declaration text is on the Department of State Web site 
at http://www.state.gov/p/eur/rls/or/126162.htm.
    The Department will host a Town Hall Meeting on September 22 from 
9:45 a.m. to 12 noon to obtain expert views on the following:
    (a) Expanding systematic provenance research;
    (b) Making the results of such research available to the art 
community;
    (c) Developing alternative mechanisms to resolve claims for 
artworks displaced as a result of the Holocaust and World War II.
    Individuals wishing to attend this town hall meeting should 
register no later than September 20 by e-mailing the following 
information to Ms. Carolyn Jones-Johnson (<a href="/cdn-cgi/l/email-protection#efa580818a9cc2a58087819c8081acabaf9c9b8e9b8ac1888099"><span class="__cf_email__" data-cfemail="e2a88d8c8791cfa88d8a8c918d8ca1a6a29196839687cc858d94">[email protected]</span></a>): 
Full Name; Date of Birth;
    Number of Government-issued Picture ID (Driver's License Number, 
including State of Issuance, U.S. Passport or Alternate Government-
Issued Picture ID);
    Organization which you represent, and its Address and Phone Number;
    Home Address (only if attending as an individual).
    Those who register are urged to arrive at the Department by 9:30 
a.m. to allow time for security screening. Upon arrival, you will need 
to show valid government-issued identification: For example, a U.S. 
state driver's license or a U.S. passport. The official address of the 
State Department is 2201 C Street, NW., Washington, DC. Attendees 
should use the ``23rd Street Entrance'' on the West Side of the State 
Department's Harry S. Truman Building, located on 23rd Street between C 
Street and D Street, NW., Washington, DC.
    Written comments on the above subjects may also be provided to the 
same e-mail address for Ms. Jones-Johnson cited above.

    Dated: August 25, 2009.
Ambassador J. Christian Kennedy,
Special Envoy for Holocaust Issues, Department of State.
[FR Doc. E9-20935 Filed 8-28-09; 8:45 am]
BILLING CODE 4710-23-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
###### Editorial Note on Subchapter A of Chapter II

#### Editorial Note:

Nomenclature changes to subchapter A appear at 78 FR 60697, Oct. 2, 2013.

###### Editorial Note on Part 360

#### Editorial Note:

Nomenclature changes to part 360 appear at 79 FR 8860, Feb. 14, 2014.

#### § 360.72 [Reserved]
# C_2005311EN.01001401.xml

| 9.12.2005 | EN | Official Journal of the European Union | C 311/14 |
| --- | --- | --- | --- |

9.12.2005

EN

Official Journal of the European Union

C 311/14

---

Non-opposition to a notified concentration

(Case COMP/M.3959 — Goldman Sachs/Ihr Platz)

(2005/C 311/03)

(Text with EEA relevance)

On 9 November 2005, the Commission decided not to oppose the above notified concentration and to declare it compatible with the common market. This decision is based on Article 6(1)(b) of Council Regulation (EC) No 139/2004. The full text of the decision is available only in English and will be made public after it is cleared of any business secrets it may contain. It will be available:

| — | from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes, |
| --- | --- |

—

from the Europa competition web site (http://europa.eu.int/comm/competition/mergers/cases/). This web site provides various facilities to help locate individual merger decisions, including company, case number, date and sectoral indexes,

| — | in electronic form on the EUR-Lex website under document number 32005M3959. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex) |
| --- | --- |

—

in electronic form on the EUR-Lex website under document number 32005M3959. EUR-Lex is the on-line access to European law. (http://europa.eu.int/eur-lex/lex)

---
# Russia

1815 items

        -    Remarks  		Secretary Antony J. Blinken at a Meeting with Civil Society Representatives	  Antony J. BlinkenMay 14, 2024Coffee ShopKyiv, Ukraine 
        -    Readout  		Secretary Blinken’s Meeting with Ukrainian President Zelenskyy	  May 14, 2024 
        -    Notice to the Press  		Secretary Blinken to Deliver Remarks at Kyiv Polytechnic Institute	  May 13, 2024 
        -    Press Statement  		Secretary Blinken’s Travel to Ukraine	  Matthew MillerMay 13, 2024 
        -    Department Press Briefing  		Department Press Briefing – May 13, 2024	  Vedant PatelMay 13, 2024 
        -    Press Statement  		United States Announces Significant New Military Assistance for Ukraine	  Antony J. BlinkenMay 10, 2024 
        -    Media Note  		Joint Statement by the U.S. Department of State and UK Foreign, Commonwealth and Development Office:  Second U.S.-UK Strategic Sanctions Dialogue	  May 9, 2024 
        -    Media Note  		Senior Official for the Democratic People’s Republic of Korea (DPRK) Pak’s Meeting with People’s Republic of China (PRC) Special Representative on Korean Peninsula Affairs Liu	  May 9, 2024 
        -    Department Press Briefing  		Department Press Briefing – May 8, 2024	  Matthew MillerMay 8, 2024 
        -    Department Press Briefing  		Department Press Briefing – May 7, 2024	  Matthew MillerMay 7, 2024Washington, D.C. 

previous page123456…182next page

Back to Top
Document headings vary by document type but may contain
                    the following: the agency or agencies that issued and signed a document
the number of the CFR title and the number of each part
                      the document amends, proposes to amend, or is directly
                      related to
the agency docket number / agency internal file number
the RIN which identifies each regulatory action listed in
                      the Unified Agenda of Federal Regulatory and Deregulatory
                      Actions See the
                    Document Drafting Handbook
                    for more details.
 Department of Justice Drug Enforcement Administration
 By Notice dated April 17, 2009, and published in the 
                    **Federal Register**
                     on April 29, 2009, (74 FR 19598), Cambrex Charles City, Inc., 1205 11th Street, Charles City, Iowa 50616, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedule II: Drug
ScheduleAmphetamine (1100)
IIMethamphetamine (1105)
IILisdexamfetamine (1205)
IIMethylphenidate (1724)
IIPhenylacetone (8501)
IICodeine (9050)
IIOxycodone (9143)
IIHydromorphone (9150)
IIDextropropoxyphene, bulk (non-dosage forms) (9273)
IIMorphine (9300)
IIThebaine (9333)
IISufentanil (9740)
IIFentanyl (9801)
II
 The company plans to manufacture the listed controlled substances in bulk for sale to its customers. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Cambrex Charles City, Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Cambrex Charles City, Inc. to ensure that the company's registration is consistent with the public interest. The investigation has included inspection and testing of the company's physical security systems, verification of the company's compliance with state and local laws, and a review of the company's background and history. Therefore, pursuant to 21 
                    *U.S.C.*
                     823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. Dated: August 21, 2009. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration.


[FR Doc. E9-21528 Filed 9-4-09; 8:45 am] BILLING CODE 4410-09-P
#### § 591.501 General and specific licensing procedures.

For provisions relating to licensing procedures, see part 501, subpart E of this chapter. Licensing actions taken pursuant to part 501 of this chapter with respect to the prohibitions contained in this part are considered actions taken pursuant to this part. General licenses and statements of licensing policy relating to this part also may be available through the Venezuela sanctions page on OFAC's Web site: *www.treasury.gov/ofac.*
EXHIBIT
32


CERTIFICATION PURSUANT TO RULE 13a-14(b)
and




18
U.S.C. SECTION 1350,




AS
ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002






In
connection with the filing by Apollo Solar Energy, Inc. (the "Company") of the
Quarterly Report on Form 10-Q for the period ending September 30, 2008 (the
"Report"), I, Renyi Hou, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the
Sarbanes-Oxley Act of 2002, that:






1. The
Report fully complies with the requirements of Section 13(a) and 15(d) of the
Securities Exchange Act of 1934; and






2. The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operation of the Company.




November 12,
      2008
            /s/ Renyi Hou


Renyi
      Hou (Chief Executive Officer)




November 12,
      2008
            /s/ Yong Ling Yong
      Ling (Chief Financial
Officer)
§ 2.51 Medical emergencies. ( a ) *General rule.* Under the procedures required by paragraph (c) of this section, patient identifying information may be disclosed to medical personnel to the extent necessary to: ( 1 ) Meet a bona fide medical emergency in which the patient's prior written consent cannot be obtained; or
( 2 ) Meet a bona fide medical emergency in which a part 2 program is closed and unable to provide services or obtain the prior written consent of the patient, during a temporary state of emergency declared by a state or federal authority as the result of a natural or major disaster, until such time that the part 2 program resumes operations.
( b ) *Special rule.* Patient identifying information may be disclosed to medical personnel of the Food and Drug Administration (FDA) who assert a reason to believe that the health of any individual may be threatened by an error in the manufacture, labeling, or sale of a product under FDA jurisdiction, and that the information will be used for the exclusive purpose of notifying patients or their physicians of potential dangers.
( c ) *Procedures.* Immediately following disclosure, the part 2 program shall document, in writing, the disclosure in the patient's records, including: ( 1 ) The name of the medical personnel to whom disclosure was made and their affiliation with any health care facility;
( 2 ) The name of the person making the disclosure;
( 3 ) The date and time of the disclosure; and
( 4 ) The nature of the emergency (or error, if the report was to FDA).
[82 FR 6115, Jan. 18, 2017, as amended at 85 FR 43038, July 15, 2020; 89 FR 12628, Feb. 16, 2024]
# C_2005155EN.01002501.xml

| 25.6.2005 | EN | Official Journal of the European Union | C 155/25 |
| --- | --- | --- | --- |

25.6.2005

EN

Official Journal of the European Union

C 155/25

---

Action brought on 4 April 2005 by Federico José Garcia Resusta against the Commission of the European Communities

(Case T-147/05)

(2005/C 155/48)

Language of the case: French

An action against the Commission of the European Communities was brought before the Court of First Instance of the European Communities on 4 April 2005 by Federico José Garcia Resusta, residing in Brussels, represented by Jean Van Rossum, lawyer, with an address for service in Luxembourg.

The applicant claims that the Court should:

| — | annul the Commission's decision to dismiss the applicant's request for recognition of the occupational origin of his disease or aggravation thereof, which prevents him from performing the tasks associated with a post in his category and grade, |
| --- | --- |

—

annul the Commission's decision to dismiss the applicant's request for recognition of the occupational origin of his disease or aggravation thereof, which prevents him from performing the tasks associated with a post in his category and grade,

| — | order the defendant to pay the costs. |
| --- | --- |

—

order the defendant to pay the costs.

Pleas in law and main arguments

The Commission adopted the contested decision following the judgment of 23 November 2004 of the Court of First Instance in Case T-376/02 (1), which annulled the Commission's decision of 14 January 2002 awarding the applicant an invalidity pension.

1

In support of his action, the applicant alleges infringement of the obligation to state reasons and infringement of Article 3 of the Rules on the insurance of officials of the European Communities against the risk of accident and of occupational disease, on the grounds that the opinion of the Medical Committee, which decided that it had not been established sufficiently that the aggravation of the applicant's disease had a direct connection with the duties he had performed, was contrary to the opinion of the Invalidity Committee, which had found the applicant's pre-existing disease had been aggravated by the stress related to his duties.

---

(1)  Application published in OJ 2003 C 44 of 22.2.2003, p. 37, judgment published in OJ 2004 C 45 of 19.2.2005, p. 23.

1

---
EX-10.11





 EXHIBIT 10.11 

[***] Certain information in this document has been excluded pursuant to Regulation S-K, Item
601(b)(10). 
 Such excluded information is not material and would likely cause competitive harm to the registrant if publicly disclosed. 

SECOND AMENDMENT 
 BILL
PAY SERVICE RESELLER AGREEMENT 
 This Second Amendment to Bill Pay Service Reseller Agreement (“Second Amendment”) is dated
as of this 11th day of February, 2016 by and between CO-OP eCom, LLC, a California limited liability company (“eCom”) and Alkami Technology, Inc., a Delaware Corporation (“Reseller”) with
reference to the following facts and circumstances: 
 RECITALS 

A. The parties have entered into the following Bill Pay Service Reseller Agreement dated June 28, 2013 and Revised Exhibit A Service Description and
Bill Payment Services Fees date October 2. 2013 (the “Agreement”). 
 All terms not defined in this Second Amendment have the meanings
defined in the Agreement. 
 NOW, THEREFORE, in consideration of the premises and of the mutual provisions, agreements and covenants herein, the parties
hereby amend the Agreement as follows: 
  

	1.	 eCom shall allow Reseller to offer the following reduced pricing to selected clients that have transaction
volumes of [***] or higher per month. Reseller will be required to submit an approval request via email to eCom, at [    ]@co-opfs.orq, for each credit union. 



For approved credit unions, eCom agrees to bill Reseller Monthly Transaction Fees as follows- 

Monthly Transaction Fees: 
  

					
	 [***] transactions
	  	$	[	***] 
	 [***] transactions
	  	$	[	***] 
	 [***] + transactions
	  	$	[	***] 

 This tiered pricing structure above will be applicable to each credit union individually, not to the collective
volumes of all the credit unions subject to this pricing. The transaction volume associated with this pricing will not be included in the calculation of total transaction volume to determine Alkami’s tiered Monthly Transaction Fees as set forth
in the Agreement. 
 Reseller agrees that attached Exhibit A contains a current, complete list of credit unions receiving reduced
pricing. Reseller further agrees that each January 1 and July 1 hereafter Reseller will furnish eCom with the then current and complete new Exhibit A. 
  

	2.	 Second Amendment’s Effect on Agreement. Except as modified by the changes set forth above in this Second
Amendment, all terms and conditions of the Agreement shall continue in full force and effect. 














 The parties have caused this Second Amendment to be executed as of the date first written above. 

 

					
	 CO-OP eCom, LLC
	 		  	 Alkami Technology, Inc

	 1317 South Fountain Drive
	 		  	 5601 Granite Parkway Suite 120

	 Olathe, KS 66061
	 		  	 Plano, TX 75024

			
	 By: /s/ Kimberly Hester
	 		  	 By: /s/ Douglas Linebarger

	Signature	 		  	Signature
			
	 Kimberly Hester
	 		  	 Douglas Linebarger

	Name (Please Print)	 		  	Name (Please Print)
			
	 Manager
	 		  	 General Counsel

	Title (Please Print)	 		  	Title (Please Print)
			
	 February 11, 2016
	 		  	 February 11, 2016

	Date	 		  	Date
c:\documents and settings\tvanjani\my documents\bart\bart protocols & reports\interstate paper\ga-intpaper-4km-28aug2006.doc1INTERSTATE PAPER, LLCGeorgiaVisibility Results for 2001-2003 CALPUFF ScreeningRunsCALPOST, Method 6Using annual average Haze Index (HI) values in processingTable 1. Stack parameters and emissionsLambert ConformalCoordinatesStackID #LCC East LCC NorthStackHeightBaseElevationDiameterGas ExitVelocityStackGasExitTemp.SO2EmissionsSO4EmissionsNOxEmissionsPM10EmissionsPM2.5EmissionsNH3Emissionskm km m m m m/s K g/s g/s g/s g/s g/s g/sPB 1470.712 -789.031 46.04 4.30 1.98 15.45 470.92 60.5000 0.0000 8.7000 3.4000 2.0000LK 1470.714 -788.897 15.24 3.60 1.52 4.96 342.09 0.1600 0.0000 2.2000 0.7400 0.7200RB 1470.714 -789.026 46.04 4.20 2.74 13.73 353.37 0.1200 0.0000 8.8000 5.5000 5.4000Table 2. Particle Speciationparticle speciation CondensableFilterableStack ID#filterablePM10condensable PM10organiccondensable (OC)inorganiccondensableCOARSE Soil Elemental Carbon (EC)% %0.625-1.0μm(g/s)0.5-0.625μm(g/s)0.625-1.0μm(g/s)0.5-0.625μm(g/s)6-10μm(g/s)2.5-6μm(g/s)1.25-2.5μm(g/s)1.0-1.25μm(g/s)0.625-1.0μm(g/s)0.5-0.625μm(g/s)1.25-2.5μm(g/s)1.0-1.25μm(g/s)0.625-1.0μm(g/s)0.5-0.625μm(g/s)PB1.7000 1.7000LK0.3700 0.3700RB2.7500 2.7500Note: Stack parameters and emission data obtained from “EPD BART Emissions.xls” file. The PM speciation was not provided by the state. All PM10- H2SO4emissions were equally dividedbetween the two size categories of OC. This is a conservative approach since, Organic condensable haveextinction efficiency of 4 m2/g.c:\documents and settings\tvanjani\my documents\bart\bart protocols & reports\interstate paper\ga-intpaper-4km-28aug2006.doc2Table 3. Summary of Visibility ResultsClass I Area 2001 2002 2003AnnualaveragebackgroundbextMaximum delta-deciview, (# days>0.5 dv, # days >1 dv)(Mm-1)Cape Romain 0.330 (0 0) 0.408 (0 0) 0.242 (00) 21.22Okefenokee0.670 (4 0) 0.561 (3 0) 1.153 (4 1)21.41St Marks 0.192 (0 0) 0.196 (0 0) 0.247 (0 0) 21.54Wolf Island1.653 (8 1) 0.963 (12 0) 0.938 (10 0)21.33Table 4. Visibility Results – 8 highest values2001 2002 2003Change inDeciview (dv)DayChange inDeciview (dv)DayChange inDeciview (dv)Day RankOkefenokee0.6700.5790.5200.5140.4310.4310.4310.318Feb 13Nov 19Oct 22Dec 4Jun 20Feb 12Jan 14Oct 230.5610.5160.5000.4620.4610.4560.4010.338Dec 8Oct 22Jan 27Oct 25Dec 18Jan 26Oct 14Feb 31.1530.6300.5230.5000.3910.3410.3360.328Jan 31Dec 27Nov 8Sep 10Nov 21Oct 31Jan 28Nov 1112345678Wolf Island1.6530.8510.7590.7550.6750.6650.5840.573Jan 15Sep 17Jan 10Feb 6Jan 21Sep 9Sep 18Dec 210.9630.9620.9430.8230.7510.7310.6910.650Jan 28Dec 27Nov 26Sep 17Nov 1Dec 30Jan 16Oct 260.9380.7630.7600.7070.6300.6090.5740.565Dec 8Sep 7Sep 8Jul 15Nov 22Oct 15Oct 4Nov 712345678
Exhibit 23.2
                      Consent of Deloitte and Touche L.L.P.

[LOGO]

INDEPENDENT AUDITORS' CONSENT

We consent to the incorporation by reference in the Registration Statements of
Omega Financial Corporation on Form S-8 (File No. 33-15780 and File No.
33-82214) of the report of Deloitte & Touche LLP dated January 28, 1994, on Penn
Central Bancorp, Inc. and subsidiaries appearing in thew Annual report on Form
10-K of Omega Financial Corporation for the year ended December 31, 1995.


Deloitte & Touche LLP
Pittsburgh, PA.
March 25, 1996
# Thailand

170 items

        -    Report  		Country Reports on Terrorism 2019: Thailand	  June 24, 2020 
        -    Report  		2019 Report on International Religious Freedom: Thailand	  June 10, 2020 
        -    Report  		2019 Country Reports on Human Rights Practices: Thailand	  March 11, 2020 
        -    Report  		2019 END Wildlife Trafficking Report	  November 7, 2019 
        -    Fact Sheet  		The U.S.-Thai Alliance and U.S. Partnership With ASEAN	  October 21, 2019 
        -    Report  		Thailand	  July 11, 2019 
        -    Report  		Thailand	  June 21, 2019 
        -    Report  		Thailand	  June 20, 2019 
        -    		Thailand	  April 22, 2019 
        -    Report  		Thailand	  March 13, 2019 

previous page1…121314151617next page

Back to Top
#### STATE of Louisiana v. Jeff LEE.

No. 80-K(A)-2704.

Supreme Court of Louisiana.

Jan. 9, 1981.

In re State of Louisiana, through the District Attorney, Marion B. Farmer, applying for remedial writs. Parish of St. Tammany. No. 79437.

Granted.